About Alvéole
Alvéole is a company based in Paris (France) founded in 2010. It operates as a Direct-to-Consumer (D2C). Alvéole has raised $1.16 million across 2 funding rounds from investors including Le Village by CA and Le Quattrocento. Alvéole offers products and services including PRIMO, LEONARDO, PLPP, and PDMS Stencil. Alvéole operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.16 M (USD)
in 2 rounds
-
Latest Funding Round
$1.16 M (USD), Seed
Oct 16, 2018
-
Investors
Le Village by CA
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alvéole
Alvéole offers a comprehensive portfolio of products and services, including PRIMO, LEONARDO, PLPP, and PDMS Stencil.
Bioengineering tool for creating smart cell culture substrates.
Software for enhancing bioengineering and micropatterning processes.
Reagent used in bioengineering for cell culture applications.
Tool for structuring hydrogels in cell biology research.
Funding Insights of Alvéole
Alvéole has successfully raised a total of $1.16M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.16 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Alvéole
Alvéole has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Le Village by CA and Le Quattrocento.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated sector-agnostically by Le Village by CA.
|
Locked | Locked | Locked | |
|
Promising academic inventions are developed into life science startups.
|
Locked | Locked | Locked |
Investor details for Alvéole
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alvéole
Investment portfolio details for Alvéole
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alvéole
Detailed financials for Alvéole
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alvéole Comparisons
Peer comparison for Alvéole
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alvéole
Alvéole operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Alvéole
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alvéole
Complete news archive for Alvéole
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alvéole
Alvéole was founded in 2010 and raised its 1st funding round 8 years after it was founded.
Alvéole is headquartered in Paris, France.
Romuald Vally is the current CEO of Alvéole.
Alvéole is a funded company, having raised a total of $1.16M across 2 funding rounds to date.
Alvéole is engaged in the development of bioengineering tools aimed at accelerating cell biology research. The company offers a range of products, including PRIMO for micropatterning and smart cell culture substrates, alongside complementary tools like LEONARDO software and PDMS stencils. Solutions provided by Alvéole are utilized by academic laboratories to enhance reliability and reproducibility in cell models. The focus is placed on user needs, ensuring innovations are tailored to practical research applications within the biotechnology sector.
Alvéole's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Alvéole offers PRIMO, LEONARDO, PLPP, and PDMS Stencil.
Alvéole has 2 investors. Key investors include Le Village by CA, and Le Quattrocento.